Michel Lagarde
Net Worth

Last updated:

What is Michel Lagarde net worth?

The estimated net worth of Mr. Michel Lagarde is at least $112,429,320 as of 14 May 2024. He owns shares worth $8,962,730 as insider, has earned $86,016,590 from insider trading and has received compensation worth at least $17,450,000 in Thermo Fisher Scientific Inc..

What is the salary of Michel Lagarde?

Mr. Michel Lagarde salary is $3,490,000 per year as Executive Vice President & Chief Operating Officer in Thermo Fisher Scientific Inc..

How old is Michel Lagarde?

Mr. Michel Lagarde is 50 years old, born in 1975.

What stocks does Michel Lagarde currently own?

As insider, Mr. Michel Lagarde owns shares in one company:

Company Title Shares Price per share Total value
Thermo Fisher Scientific Inc. (TMO) Executive Vice President & Chief Operating Officer 18,134 $494.25 $8,962,730

What does Thermo Fisher Scientific Inc. do?

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Michel Lagarde insider trading

Thermo Fisher Scientific Inc.

Mr. Michel Lagarde has made 28 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 34,168 units of TMO stock on 7 May 2021. As of 14 May 2024 he still owns at least 18,134 units of TMO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 20,000 $105.17 $2,103,400
Sale
Common Stock 20,000 $590.05 $11,801,000
Option
Common Stock 20,000 $105.17 $2,103,400
Option
Stock Option (Right to Buy) 3,893 $458.81 $1,786,147
Sale
Common Stock 3,117 $564.23 $1,758,705
Sale
Common Stock 8,731 $565.18 $4,934,587
Sale
Common Stock 1,182 $566.16 $669,201
Option
Stock Option (Right to Buy) 10,715 $253.99 $2,721,503
Option
Stock Option (Right to Buy) 6,049 $210.68 $1,274,403
Option
Stock Option (Right to Buy) 9,137 $309.63 $2,829,089
Option
Common Stock 9,137 $309.63 $2,829,089
Option
Common Stock 3,893 $458.81 $1,786,147
Sale
Common Stock 2,139 $537.4 $1,149,499
Sale
Common Stock 7,083 $536.25 $3,798,259
Option
Common Stock 6,049 $210.68 $1,274,403
Sale
Common Stock 7,542 $535.38 $4,037,836
Option
Common Stock 10,715 $253.99 $2,721,503
Sale
Common Stock 826 $542.74 $448,303
Option
Stock Option (Right to Buy) 14,900 $190.59 $2,839,791
Option
Stock Option (Right to Buy) 2,250 $294.02 $661,545
Option
Stock Option (Right to Buy) 1,851 $210.68 $389,969
Option
Stock Option (Right to Buy) 3,197 $253.99 $812,006
Option
Common Stock 1,851 $210.68 $389,969
Option
Common Stock 3,197 $253.99 $812,006
Sale
Common Stock 200 $545.96 $109,192
Sale
Common Stock 472 $545.16 $257,316
Sale
Common Stock 357 $544.4 $194,351
Sale
Common Stock 2,068 $541.95 $1,120,753
Sale
Common Stock 1,125 $540.85 $608,456
Sale
Common Stock 542 $545.04 $295,412
Sale
Common Stock 3,392 $549.99 $1,865,566
Option
Common Stock 2,250 $294.02 $661,545
Sale
Common Stock 2,792 $549.07 $1,533,003
Sale
Common Stock 4,908 $548.05 $2,689,829
Option
Common Stock 14,900 $190.59 $2,839,791
Sale
Common Stock 3,783 $547.13 $2,069,793
Sale
Common Stock 700 $550.94 $385,658
Sale
Common Stock 1,033 $546.1 $564,121
Sale
Common Stock 1,000 $541.52 $541,515
Sale
Common Stock 5,100 $541.25 $2,760,375
Sale
Common Stock 21,600 $465.07 $10,045,512
Option
Common Stock 21,600 $190.59 $4,116,744
Option
Stock Option (Right to Buy) 21,600 $190.59 $4,116,744
Sale
Common Stock 34,168 $473.81 $16,189,174
Option
Common Stock 29,100 $190.59 $5,546,169
Option
Stock Option (Right to Buy) 29,100 $190.59 $5,546,169
Sale
Common Stock 34,168 $473.81 $16,189,174
Sale
Common Stock 7,290 N/A N/A
Sale
Common Stock 12,000 N/A N/A
Sale
Common Stock 12,000 N/A N/A